This Clinic Offers Wharton’s Stem Cell Therapy For Parkinson's  TrinityStem Cells has now introduced WJ-MSC therapies for neurodegenerative diseases such as Parkinson's and Alzheimer's. This treatment is also known as UC-MSC therapy. It takes advantage of these cells’ ability to modulate the immune system, inhibit inflammation, and promote regeneration of the target tissue.   This allows your body to replace lost cells and facilitate the repair process of your existing cells. Wharton's jelly stem cells, derived from the gelatinous connective tissue of umbilical cords, are among the most well-studied regenerative medicine sources - and are considered the new benchmark for MSC-based therapies. Stem cells are typically administered into your body using IV solution or injections. After the stem cells are positioned in an environment of damaged tissue, injured cells are nourished, and other cells are stimulated to join in the healing process - in what are termed the paracrine and autocrine effects. Trinity Stem Cells was founded to provide the global community with treatments that few people know are available, and to offer health outcomes that exceed what most people ever imagined were feasible. The clinic's medical director is Dr. Anna Lara Kattan, MD. She is a member of the International Society for Stem Cell Application. One Trinity patient suffering from diabetes said: "I'm thrilled how quickly Trinity Stem Cell's treatment is working to restore my pancreas. In three days after my stem cell treatment, my glucose readings are the lowest since being diagnosed with diabetes ten years ago.” Click on the link in the description for more information.